Spinnaker Trust’s GSK GSK Stock Holding History

Spinnaker Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,278	Closed	-$228K	–	241
2019 Q3	$228K	Buy	4,278 +40	+0.9%	+$2.06K	0.02%	230
2019 Q2	$211K	Hold	4,238	–	–	0.02%	224
2019 Q1	$221K	Sell	4,238 -320	-7%	-$16K	0.02%	223
2018 Q4	$217K	Buy	4,558 +40	+0.9%	+$1.97K	0.02%	208
2018 Q3	$226K	Buy	+4,518	New	+$230K	0.02%	215
2017 Q2	–	Sell	-4,316	Closed	-$227K	–	202
2017 Q1	$227K	Buy	+4,316	New	+$219K	0.03%	187
2014 Q3	–	Sell	-4,240	Closed	-$283K	–	186
2014 Q2	$283K	Hold	4,240	–	–	0.05%	151
2014 Q1	$283K	Sell	4,240 -280	-6%	-$18.9K	0.05%	151
2013 Q4	$302K	Hold	4,520	–	–	0.05%	140
2013 Q3	$283K	Hold	4,520	–	–	0.05%	135
2013 Q2	$282K	Buy	+4,520	New	+$287K	0.05%	129

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Spinnaker Trust's GSK Position: Q4 2019 in Review

Spinnaker Trust sold out of GSK (GSK) in Q4 2019, closing a stake of 4,278 shares — an estimated $228K sold.

Spinnaker Trust first reported a position in GSK in Q2 2013 and held it in 11 quarters. The position peaked at $302K in Q4 2013. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Spinnaker Trust reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Spinnaker Trust sold 4,278 GSK shares in Q4 2019, an estimated $228K.
Spinnaker Trust first reported a position in GSK in Q2 2013 and held it in 11 quarters.
Spinnaker Trust's GSK position peaked at $302K in Q4 2013.
894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Spinnaker Trust's 13F filing for Q4 2019, filed 5 Feb 2020.